PFBT
EWTX icon

Parkside Financial Bank & Trust’s Edgewise Therapeutics EWTX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.42K Hold
35
– – ﹤0.01% 2300
2026
Q1 		$1.1K Hold
35
– – ﹤0.01% 2324
2025
Q4 		$869 Hold
35
– – ﹤0.01% 2385
2025
Q3 		$569 Hold
35
– – ﹤0.01% 2511
2025
Q2 		$459 Sell
35
-5
-13% -$72 ﹤0.01% 2591
2025
Q1 		$880 Buy
+40
New +$1.05K ﹤0.01% 2155

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parkside Financial Bank & Trust's EWTX Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Edgewise Therapeutics (EWTX) position steady in Q2 2026 at 35 shares worth $1.42K. The position accounts for ﹤0.01% of the portfolio, ranked #2300.

Parkside Financial Bank & Trust first reported a position in EWTX in Q1 2025 and has held it in 6 quarters since. 226 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Parkside Financial Bank & Trust held 35 shares of Edgewise Therapeutics worth $1.42K as of Q2 2026.
  • Parkside Financial Bank & Trust left its Edgewise Therapeutics share count unchanged in Q2 2026.
  • Edgewise Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2300 holding.
  • Parkside Financial Bank & Trust first reported a position in Edgewise Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 226 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.